SCHEMBL26024319

SCHEMBL26024319

O=c1c(N=C=S)cc(C2CC2)cn1C1CC[C@H]1O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24007158 1.00 — —
SCHEMBL24007996 1.00 — —
SCHEMBL24815068 0.82 — —
SCHEMBL24007985 0.77 — —
SCHEMBL26024125 0.77 — —
SCHEMBL24007993 0.77 — —
SCHEMBL24816350 0.77 — —
SCHEMBL26012057 0.76 EPHX2 (0.31) —
SCHEMBL24008091 0.75 SLC18A3 (0.36) —
SCHEMBL24007157 0.75 SLC18A3 (0.33) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230265075-A1 6-HETEROARYLOXY BENZIMIDAZOLES AND AZABENZIMIDAZOLES AS JAK2 INHIBITORS AJAX THERAPEUTICS, INC. 2023-08-24 — — US disclosed
Send feedback